Moderna reveals positive results from Phase 1 Covid-19 vaccine trial
Category: #health  By Saipriya Iyer  Date: 2020-07-15
 | 
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Moderna reveals positive results from Phase 1 Covid-19 vaccine trial

The dire need for a treatment for the coronavirus has compelled pharmaceutical companies worldwide to fast track clinical trials. U.S.-based biotech company, Moderna Inc. has recently made some developments, with its researchers claiming that their experimental COVID-19 vaccine was demonstrated to be safe and accelerated immune responses in all 45 healthy volunteers that took part in an ongoing early-stage trial.

According to credible reports, volunteers subjected to two vaccine doses reported high levels of virus-killing antibodies that surpassed average levels seen in patients that had recovered from the virus. Volunteers also didn’t experience any serious side effects, though some reported mild/moderate reactions like headache, fatigue, chills, muscle pain or aches at vaccine injected site.

Dr. Anthony Fauci, Director of NIAID (National Institute of Allergy and Infectious Diseases), praised recent developments by Moderna, adding that the study found no serious side effects and the vaccine produced relatively higher levels of virus-killing or neutralizing antibodies.

Until now, the coronavirus pandemic has impacted millions of lives and has caused nearly 575,000 deaths globally. Moderna was the first company to start human trial of its vaccine for COVID-19 in March.

With noteworthy strides made by Moderna, the US government is supporting the pharma giant’s vaccine with around half a billion dollar worth of funding and has selected its vaccine as one of the first to enter large-scale human trials.

For the uninitiated, Moderna’s mRNA-1273 uses ribonucleic acid (RNA), a chemical messenger which contains instructions for protein development. After being injected to a subject, the vaccine directs cells to make proteins that mimic the outer layer of the coronavirus, which the body identifies as a foreign object, and accelerates its immune response against it.

With pharma companies worldwide accelerating their efforts towards vaccine development, sources cite that a successful vaccine could be a significant milestone for Moderna, which has never had a licensed product.

Source Credit: https://www.hindustantimes.com/world-news/moderna-phase-1-results-show-covid-19-vaccine-safe-induces-immune-response/story-vEMNOUskkkCfSeX0yBRViI.html



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

Stc Bahrain, Crayon & Microsoft partner to equip firms with new tech

Stc Bahrain, Crayon & Microsoft partner to equip firms with new tech

By Saipriya Iyer

Stc Bahrain, a leading digital enabler, inked a strategic alliance agreement with Crayon and Microsoft to provide Microsoft services portfolio to its business clients. As part of its collaboration with Crayon, a Micros...

Retailers under pressure to offer value despite declining sales

Retailers under pressure to offer value despite declining sales

By Saipriya Iyer

According to credible sources, retailers are being forced to strengthen their value credentials, as the budgets of consumers become more constrained throughout the holiday season.

Volatus Aerospace acquires iRed Limited to expand presence in UK

Volatus Aerospace acquires iRed Limited to expand presence in UK

By Saipriya Iyer

Volatus Aerospace Corp. recently announced that it had signed an agreement to acquire iRed Limited, a British company that specializes in drone services and training. The acquisition will reportedly create a foundation...